Business Description
Enimmune Corp
ISIN : TW0006564008
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.31 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 7.51 | |||||
Beneish M-Score | 2.07 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.6 | |||||
3-Year EBITDA Growth Rate | -40.4 | |||||
3-Year EPS without NRI Growth Rate | -34.5 | |||||
3-Year FCF Growth Rate | -0.1 | |||||
3-Year Book Growth Rate | -21.9 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.1 | |||||
9-Day RSI | 59.33 | |||||
14-Day RSI | 57.78 | |||||
6-1 Month Momentum % | -12.17 | |||||
12-1 Month Momentum % | -36.3 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.71 | |||||
Quick Ratio | 2.62 | |||||
Cash Ratio | 2.21 | |||||
Days Inventory | 235.87 | |||||
Days Sales Outstanding | 60.22 | |||||
Days Payable | 60.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | -1.01 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -53.74 | |||||
Operating Margin % | -559.4 | |||||
Net Margin % | -514.42 | |||||
FCF Margin % | -317.59 | |||||
ROE % | -50.31 | |||||
ROA % | -32.05 | |||||
ROIC % | -125.97 | |||||
ROC (Joel Greenblatt) % | -708.79 | |||||
ROCE % | -41.97 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 54.39 | |||||
PB Ratio | 7.35 | |||||
Price-to-Tangible-Book | 11.11 | |||||
EV-to-EBIT | -9.52 | |||||
EV-to-EBITDA | -9.84 | |||||
EV-to-Revenue | 51.79 | |||||
EV-to-FCF | -16.31 | |||||
Price-to-Net-Current-Asset-Value | 12.96 | |||||
Price-to-Net-Cash | 24.42 | |||||
Earnings Yield (Greenblatt) % | -10.5 | |||||
FCF Yield % | -5.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Enimmune Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 43.494 | ||
EPS (TTM) (NT$) | -3.394 | ||
Beta | 0.27 | ||
Volatility % | 21.14 | ||
14-Day RSI | 57.78 | ||
14-Day ATR (NT$) | 1.166444 | ||
20-Day SMA (NT$) | 34.8375 | ||
12-1 Month Momentum % | -36.3 | ||
52-Week Range (NT$) | 31.34628 - 53.108984 | ||
Shares Outstanding (Mil) | 72.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Enimmune Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Enimmune Corp Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Enimmune Corp Frequently Asked Questions
What is Enimmune Corp(ROCO:6564)'s stock price today?
When is next earnings date of Enimmune Corp(ROCO:6564)?
Does Enimmune Corp(ROCO:6564) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |